Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial

• প্রধান লেখক: Mari Wataya-Kaneda (লেখক), Hiroshi Nagai (লেখক), Yuuki Ohno (লেখক), Hiroo Yokozeki (লেখক), Yasuyuki Fujita (লেখক), Hironori Niizeki (লেখক), Kazue Yoshida (লেখক), Masaaki Ogai (লেখক), Yuichi Yoshida (লেখক), Akihiko Asahina (লেখক), Kazuyoshi Fukai (লেখক), Chiharu Tateishi (লেখক), Izumi Hamada (লেখক), Tatsuro Takahata (লেখক), Kenji Shimizu (লেখক), Shigeki Shimasaki (লেখক), Hiroyuki Murota (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Adis, Springer Healthcare, 2020-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Introduction Our previous clinical studies have demonstrated the short-term efficacy and safety of the sirolimus gel for patients with tuberous sclerosis complex (TSC). However, long-term clinical evidence is lacking. Our objective was to assess the safety and efficacy of long-term treatmen...